11-56417478-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004744.1(OR8U3):c.755A>T(p.Tyr252Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004744.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR8U3 | NM_001004744.1 | c.755A>T | p.Tyr252Phe | missense_variant | 1/1 | ENST00000623286.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR8U3 | ENST00000623286.1 | c.755A>T | p.Tyr252Phe | missense_variant | 1/1 | NM_001004744.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152012Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000598 AC: 15AN: 250832Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135552
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461726Hom.: 0 Cov.: 35 AF XY: 0.0000289 AC XY: 21AN XY: 727162
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.755A>T (p.Y252F) alteration is located in exon 1 (coding exon 1) of the OR5R1 gene. This alteration results from a A to T substitution at nucleotide position 755, causing the tyrosine (Y) at amino acid position 252 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at